Skip to main content
Clinical Trials/NCT02741063
NCT02741063
Unknown
Early Phase 1

Oxytocin Effect on Attentional Bias Towards Emotional Expression Faces in Individuals With High and Low Autistic Traits: A Functional Magnetic Resonance Imaging (fMRI) Study

University of Electronic Science and Technology of China1 site in 1 country120 target enrollmentMay 2016

Overview

Phase
Early Phase 1
Intervention
screen high autistic subjects
Conditions
Healthy
Sponsor
University of Electronic Science and Technology of China
Enrollment
120
Locations
1
Primary Endpoint
attentional bias toward emotional expression faces
Last Updated
7 years ago

Overview

Brief Summary

to investigate whether oxytocin alter attentional bias towards emotional expression faces in individuals with high and low autistic traits, and the brain mechanism of this effect

Detailed Description

In the present study, investigator plan to use a double-blind, between-subject placebo controlled design.Firstly, all healthy male subjects' autistic trait levels will be assessed by the Autism Spectrum Quotient (ASQ) and only subjects with higher or lower ASQ score will be recruited in the next experiment and divided into high and low subgroup. Then, subjects are randomly assigned to receive either intranasal administration of oxytocin (24 IU) or placebo. 45 min later, subject need to complete an attentional bias task named rapid serial visual presentation (RSVP) task in fMRI scanner.

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
September 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
University of Electronic Science and Technology of China
Responsible Party
Principal Investigator
Principal Investigator

Keith Kendrick

Professor

University of Electronic Science and Technology of China

Eligibility Criteria

Inclusion Criteria

  • healthy subjects without past or current psychiatric or neurological disorders

Exclusion Criteria

  • history of head injury;
  • claustrophobia;
  • medical or psychiatric illness.

Arms & Interventions

high autistic and oxytocin group

subject with high ASQ scores will receive oxytocin treatment

Intervention: screen high autistic subjects

high autistic and oxytocin group

subject with high ASQ scores will receive oxytocin treatment

Intervention: oxytocin

low autistic and oxytocin group

subject with low ASQ scores will receive oxytocin treatment

Intervention: screen low autistic subjects

low autistic and oxytocin group

subject with low ASQ scores will receive oxytocin treatment

Intervention: oxytocin

high autistic and placebo group

subject with high ASQ scores will receive placebo treatment

Intervention: screen high autistic subjects

high autistic and placebo group

subject with high ASQ scores will receive placebo treatment

Intervention: placebo

low autistic and placebo group

subject with low ASQ scores will receive placebo treatment

Intervention: screen low autistic subjects

low autistic and placebo group

subject with low ASQ scores will receive placebo treatment

Intervention: placebo

Outcomes

Primary Outcomes

attentional bias toward emotional expression faces

Time Frame: 1 hour

attentional bias was measured by the accuracy of each emotional faces in the RSVP task

Secondary Outcomes

  • brain activity during RSVP task(1 hour)

Study Sites (1)

Loading locations...

Similar Trials